Expression of the TSLC1 Adhesion Molecule in Pulmonary Epithelium and Its Down-Regulation in Pulmonary Adenocarcinoma Other than Bronchioloalveolar Carcinoma
Akihiko Ito(The University of Osaka), Yukihiko Kitamura(Osaka University), Shoichi Iseki(Kanazawa University), Tomohiko Wakayama(Kumamoto University), Yu-ichiro Koma(The University of Osaka), Kazuya Uchino(Akashi Medical Center), Morihito Okada(Hiroshima University), Noriaki Tsubota(Akashi Medical Center), Yutaka Okita(Takatsuki General Hospital)
Cited by 70
Related Papers
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|642
Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial
|Journal of Thoracic and Cardiovascular Surgery|2019|496
EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ
|European Journal of Cardio-Thoracic Surgery|2023|373